Fifth Third Bancorp’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-440
| Closed | -$1.65K | – | 2517 |
|
|
2023
Q3 | $1.65K | Buy |
440
+111
| +34% | +$415 | ﹤0.01% | 2408 |
|
|
2023
Q2 | $1.41K | Buy |
329
+26
| +9% | +$111 | ﹤0.01% | 2460 |
|
|
2023
Q1 | $2.07K | Sell |
303
-53
| -15% | -$363 | ﹤0.01% | 2557 |
|
|
2022
Q4 | $2.82K | Buy |
356
+110
| +45% | +$871 | ﹤0.01% | 2356 |
|
|
2022
Q3 | $2K | Hold |
246
| – | – | ﹤0.01% | 2402 |
|
|
2022
Q2 | $2K | Buy |
+246
| New | +$2K | ﹤0.01% | 2418 |
|
|
2022
Q1 | – | Sell |
-409
| Closed | -$7K | – | 2679 |
|
|
2021
Q4 | $7K | Buy |
409
+297
| +265% | +$5.08K | ﹤0.01% | 2215 |
|
|
2021
Q3 | $2K | Buy |
+112
| New | +$2K | ﹤0.01% | 2428 |
|
|
2020
Q2 | – | Sell |
-17,545
| Closed | -$285K | – | 2092 |
|
|
2020
Q1 | $285K | Buy |
17,545
+94
| +0.5% | +$1.53K | ﹤0.01% | 739 |
|
|
2019
Q4 | $314K | Buy |
17,451
+1,854
| +12% | +$33.4K | ﹤0.01% | 802 |
|
|
2019
Q3 | $316K | Buy |
+15,597
| New | +$316K | ﹤0.01% | 779 |
|